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Strengths and limitations of this study
 ► Exploratory and confirmatory factor analyses 
were performed to assess the factor structure of 
Depression Stigma Scale (DSS).
 ► A representative sample of people with heteroge-
neous types of cancer living in Xi’an, China provided 
data for the present study.
 ► It remained unclear to what extent our findings 
could be generalised to other populations (including 
healthy or depressed persons) in other countries.
 ► Given the design of the study, we could not thor-
oughly test the construct validity and test–retest 
reliability of the DSS.
AbStrACt
Objectives The Depression Stigma Scale (DSS) is 
commonly used to assess depression stigma in the 
general population and in people with depression. The 
DSS includes two 9-item subscales assumed to measure 
personal depression stigma (ie, personal perceptions 
of depression) and perceived depression stigma (ie, 
perceptions of how others perceive depression). The aim 
of the present study was to examine its psychometric 
properties in terms of validity and reliability in Chinese 
cancer patients.
Design A cross-sectional study design.
Participants and settings This study focused on 301 
Chinese cancer patients recruited from two hospitals in 
Xi’an, China.
Methods Exploratory factor analysis (EFA) and 
confirmatory factor analysis (CFA) were used to assess 
the factor structure. Internal consistency was assessed 
using Cronbach’s alpha. To examine concurrent validity, 
symptoms of depression were used as the criterion.
results For each subscale of the DSS (ie, personal 
and perceived depression stigma), the EFA and CFA 
confirmed a two-factor structure: weak-not-sick (ie, 
perceiving that depression is not a real illness, but rather 
a sign of weakness) and discrimination (ie, perceiving 
that depressed people are discriminated against). The 
Cronbach’s alphas were adequate, ranging from 0.70 to 
0.80. Symptoms of depression were positively but weakly 
correlated to personal and perceived depression stigma.
Conclusions The DSS appeared to show satisfactory 
psychometric properties in our sample of cancer patients. 
Both personal depression stigma and perceived depression 
stigma subscales consisted of two underlying aspects.
bACkgrOunD
Currently, in China, as the number of 
cancer patients is rapidly growing, more 
than half of the Chinese cancer population 
reports elevated symptoms of depression.1 
Severe symptoms of depression can cause 
lower quality of life,2 difficulties in insisting 
on cancer treatment,3 long-term hospi-
talisation4 and elevated mortality rates.5 
Although psychological interventions have 
proven effective in treating depressive symp-
toms,6 7 only a small number of depressed 
cancer patients seem willing to seek profes-
sional help.8 9 One reason for this could be 
that people hold stigmatising beliefs and 
attitudes about depression (ie, depression 
stigma).10–12 Research on depression stigma 
to date has mainly focused on healthy individ-
uals and depressed persons, and no study has 
examined the levels and roles of depression 
stigma in cancer patients’ outcomes. One 
requirement for further research on depres-
sion stigma in cancer patients is the existence 
of a valid scale to assess depression stigma.
The Depression Stigma Scale (DSS) is 
commonly used to assess depression stigma in 
the general population and in depressed indi-
viduals.13 The 18-item DSS includes two 9-item 
unidimensional subscales: the personal depres-
sion stigma subscale reflects an individual’s 
personal attitudes towards people with depres-
sion, and the perceived depression stigma 
subscale reflects an individual’s perceived 
beliefs about the attitudes of other people.13 
The DSS has been validated to measure depres-
sion stigma in community samples and people 










pen: first published as 10.1136/bmjopen-2018-028429 on 23 July 2019. Downloaded from 
2 Zhu L, et al. BMJ Open 2019;9:e028429. doi:10.1136/bmjopen-2018-028429
Open access 
internal consistency and test–retest reliability across various 
countries including Japan,14 Germany15 and the Nether-
lands.16 Previous findings have shown that the two 9-item 
subscales comprise various factors.16
However, existing research has mainly examined the 
psychometric properties of the DSS in the general popu-
lation and people with depression, and no research has 
been conducted to examine whether the DSS is suitable 
for cancer patients. Moreover, previous research has been 
conducted on Western cultures. Given the culturally sensi-
tive experiences of depression stigma, the psychometric 
properties of the DSS cannot be assumed when used in a 
culture (such as Chinese culture) vastly different from its 
Western origins.
Before using the DSS to measure depression stigma among 
Chinese cancer patients, a crucial first step is to examine 
factor structure and internal consistency of the DSS. To fill in 
the knowledge gap, the present study focused on a heteroge-
neous sample of cancer patients in China. The primary aim 
of this study was to examine the validity and reliability of a 
Chinese version of the DSS among Chinese cancer patients. 
To examine the concurrent validity of the personal and 
perceived stigma subscale, symptoms of depression were 
used as the criterion of the personal and perceived stigma 
subscale. Given that higher perceived depression stigma was 
found to be related with higher levels of symptom severity,17 
it was expected that higher levels of depression stigma would 
be associated with more severe levels of depression.
MethODS
Sample and procedure
Shaanxi Provincial Tumour Hospital and Xijing Hospital 
(in Xi’an, China) were involved in recruiting participants 
for this cross-sectional study between May and December 
2016. Cancer patients who sought and received medical 
treatment at two hospitals were informed of this study by 
the research nurses. Eligible participants should fulfil the 
following criteria1: diagnosed with cancer,2 >18 years and3 
could read and write Chinese.
Patient and public involvement
In the current study, a self-reported questionnaire was used 
to collect data from participants. Participants were not 
involved in the design and execution of the current study. 
Findings of this study will be open to the public. However, 
we will not be able to disseminate the results to each partic-
ipant, as we did not collect their contact details.
Measures
Sociodemographic and medical characteristics
A self-report questionnaire was used to collect partici-
pants’ sociodemographic and medical characteristics. 
Educational level was classified into three levels: low 
level=primary schooling, moderate level=secondary 
schooling and high level=university education and higher.
Depression stigma
Depression stigma was measured using the 18-item DSS. 
The DSS includes two subscales: the 9-item personal 
depression stigma and the 9-item perceived depres-
sion stigma.13 The personal depression stigma subscale 
comprised the first nine items, measuring the extent to 
which each participant personally agreed with a state-
ment about depression (eg, ‘depression is a sign of 
personal weakness’). The perceived depression stigma 
subscale comprised the other nine items, measuring how 
participants perceived other people thinking about the 
same theme (eg, ‘most people believe that depression is 
a sign of personal weakness’). Each item was answered on 
a 5-point Likert scale ranging from 0 (strongly disagree) to 
4 (strongly agree). The total score of each subscale ranged 
from 0 to 36, with higher scores indicating greater stigma. 
Sufficiently good internal consistency and test–retest reli-
ability for the DSS has been reported.14 16 18
The DSS was translated into Chinese using a multiple 
forward and backward procedure based on the transla-
tion procedure of the DSS in previous studies.14–16 Two 
researchers independently translated the 18 items of the 
DSS from English to Chinese. Discrepancies in the transla-
tion procedure were identified and resolved by discussion to 
come up with a version that both researchers agreed on. A 
third native English speaker translated the Chinese version 
back into English independently. This English version was 
compared with the original English version and discrepan-
cies were discussed by all three translators until agreement 
was reached.
Symptoms of depression
The patient health questionnaire (PHQ) was originally 
developed as a depression screening module, and the 
9-item version of the PHQ (PHQ-9) has been validated as a 
reliable measure of depression severity.19 Previous research 
has validated the use of the PHQ-9 among cancer patients.20 
Each of the nine items asked patients to rate the frequency 
of depressive symptoms during the last 2 weeks on a 4-point 
Likert scale ranging from 0 (not at all) to 3 (nearly every 
day). The total score of the PHQ-9 was used to indicate the 
severity of depression, with cut-off scores of 10 or higher for 
a diagnosis of major depression. The Cronbach's alpha of 
the PHQ-9 was 0.89.
Statistical analyses
Because the personal and perceived depression stigma 
subscales used the same items (although worded slightly 
differently) to reflect various themes regarding stigmatising 
attitudes towards depression, psychometric analyses of the 
DSS were examined using the two subscales separately.
First, for the personal and perceived stigma subscales, 
we examined each of their one-factor models using confir-
matory factor analysis (CFA) with Mplus 7.3.21 Model fit 
was evaluated using the Maximum Likelihood Robust 
estimator’s Satorra-Bentler corrected χ2-test statistic 
(S-Bχ2). Other statistics to evaluate model fit were also 
used, including the Comparative Fit Index (CFI), Tuck-
er-Lewis Index (TLI), the Root-Mean-Square Error of 
Approximation (RMSEA) and Standardised Root Mean 
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Table 1 Participants’ sociodemographic and medical 




Months since diagnosis 14.25 (16.44)
Personal stigma (9-item) 18.54 (5.77)
Perceived stigma (9-item) 19.10 (5.76)
Depressive symptoms (PHQ-9) 7.33 (6.21)
%
Gender
  Male 39.6
  Female 60.4
Marital status
  Single 7.8
  Married 89.1
  Divorced 1.7
  Widowed 1.4
Educational level
  Low 27.8
  Middle 56.9
  High 15.3
Cancer type
  Breast cancer 22.3
  Lung cancer 16.7
  Gastric cancer 10.5
  Gynaecological cancer 16.7
  Colorectal cancer 4.5
  Pancreas cancer 2.8
  Liver cancer 2.1
  Lymphoma cancer 4.9
  Multiple malignant tumours 3.1
  Others 16.4
Recurrence
  Yes 28.4
  No 71.6
Cancer stage
  Stage I 18.9
  Stage II 28.4
  Stage III 21.1
  Stage IV 31.6
Type of medical treatment
  Chemotherapy 65.1
  Surgery 21.8
  Radiation 6.3
  Chinese medicine treatment 4.0
  Chemotherapy + surgery + 
radiation
1.6
  Others 1.2
CFI and TLI values >0.95 and RMSEA and SRMR values 
<0.06 indicate good model fit, and that CFI and TLI 
values >0.90 and RMSEA and SRMR values <0.08 indicate 
acceptable model fit.22
Second, if the initial CFA failed to support the 
one-factor model, exploratory factor analysis (EFA) would 
be conducted to further test the construct of personal 
and perceived depression stigma subscale using Mplus 
7.3. The EFA used the maximum likelihood estimator 
method, with oblique Geomin rotation. The number of 
factors was determined based on the scree plot and initial 
eigen-values (>1). Items were included if their primary 
loadings were 0.40 or higher. The new constructs from 
the EFA would be examined using the CFA.
Third, for each of the personal and perceived depres-
sion stigma subscale, internal consistency was examined 
using Cronbach’s α, with a value >0.70 being considered 
appropriate.23
Lastly, the concurrent validity was assessed by testing 
the correlations between the personal and perceived 
depression stigma subscales and depressive symptoms.
reSultS
Participants’ characteristics
In total, 360 cancer patients were informed, and 330 agreed 
to participate and filled out the questionnaire. The 30 
decliners did not differ significantly in age, gender or cancer 
types from the 330 other participants (p>0.05). Of those 330 
participants, 29 did not complete the questionnaire and 
were therefore excluded, and thus 301 individuals (response 
rate: 301/360=84%) were included in the data analyses. 
Those 29 participants did not differ from the 301 others in 
sociodemographic or medical characteristics (p>0.05). Each 
patient was given a coffee cup as a participation gift.
Participants’ sociodemographic and medical characteris-
tics and levels of depression stigma are shown in table 1. 
Our sample was 60.4% female, with a mean age of 50.07 
(SD=13.09). Around half had a moderate education and 
most were married. Lung, breast and gynaecological cancer 
were the most commonly reported cancer types, which is 
comparable to the cancer prevalence statistics in China.24 
The average scores on personal and perceived stigma were 
18.54 (SD=5.77) and 19.10 (SD=5.76). The average level 
of depressive symptoms in our sample was 7.33 (SD=6.21), 
with 33.7% reporting moderate-to-high levels of depressive 
symptoms (PHQ-9 ≥10).
the one-factor CFA model of the personal and perceived 
depression stigma subscales
For both the personal and perceived stigma subscales, 
the initial one-factor models fitted data poorly: for 
personal stigma subscale, S-Bχ2=139.76; df=27; CFI=0.70; 
TLI=0.60; RMSEA=0.12; SRMR=0.08; and for perceived 
stigma subscale, S-Bχ2=125.47; df=27; CFI=0.80; TLI=0.74; 
RMSEA=0.11; SRMR=0.08. These results indicate that the 
unidimensional models for the personal and perceived 
stigma subscales are not supported.
the eFA of the personal and perceived depression stigma 
subscales










pen: first published as 10.1136/bmjopen-2018-028429 on 23 July 2019. Downloaded from 
4 Zhu L, et al. BMJ Open 2019;9:e028429. doi:10.1136/bmjopen-2018-028429
Open access 
Table 2 Factor loadings from EFA of personal stigma 
subscale (n=301)
Factor loadings
Items Factor 1 Factor 2
1.People with depression could snap 
out of it if they wanted
0.74 −0.04
2.Depression is a sign of personal 
weakness
0.66 0.25
3.Depression is not a real medical 
illness
0.57 0.10
8.I would not employ someone if I 
knew they had been depressed
0.12 0.79
9.I would not vote for a politician if I 
knew they had been depressed
0.08 0.65
The boldface values indicate on which factor the items are loading 
the highest.
EFA, exploratory factor analysis.
Table 3 Factor loadings from EFA of perceived stigma subscale (n=301)
Factor loadings
Items Factor 1 Factor 2
10.Most people believe that people with depression could snap out of it if they 
wanted
−0.01 0.51
11.Most people believe that depression is a sign of personal weakness 0.21 0.66
12.Most people believe that depression is not a real medical illness 0.20 0.59
17.Most people would not employ someone they knew had been depressed 0.80 0.16
18.Most people would not vote for a politician they knew had been depressed 0.81 0.17
The boldface values indicate on which factor the items are loading the highest.
EFA, exploratory factor analysis.
structure of the subscales. The Kaiser-Meyer-Olkin 
measure indicators were 0.78 and 0.83 for the personal 
and perceived depression stigma subscales, which veri-
fied the sampling adequacy for the EFA. For the 9-item 
personal depression stigma subscale, both the eigen-
values (eigen-values >1) and the scree plot suggested a 
two-factor solution. However, items 4 and 5 displayed 
cross loadings on both factor 1 (item 4=0.24; item 5=0.30) 
and factor 2 (item 4=0.41; item 5=0.31), and items 6 and 7 
loaded <0.40. After deleting these four items, a two-factor 
solution of the personal depression stigma subscale was 
obtained and the remaining five items loaded >0.40, 
with no cross loadings >0.20 (see table 2). The two 
factors accounted for 48.86% of total variance: the first 
factor explained 31.43% of the variance and the second 
explained 17.43% of the variance. The first factor was 
labelled as weak-not-sick, comprising items about beliefs 
that the person was weak but not ill (items 1, 2, 3). The 
second factor was labelled discrimination, comprising 
items about discriminative views of people with depres-
sion (items 8, 9). Their correlation was 0.21 (p<0.001)
In addition, for the perceived stigma subscale, the 
eigen-values and the scree plot suggested a two-factor 
structure. However, item 15 displayed a cross loading 
on both factor 1 (0.32) and factor 2 (0.36), and item 13 
displayed a cross loading on both factor 1 (0.28) and 
factor 2 (0.31). Moreover, items 14 and 16 did not load 
>0.40. After deleting these four items, a two-factor solu-
tion was obtained and the remaining five items loaded 
>0.40; no cross loadings were >0.20 (see table 3). The two 
factors explained 49.25% of total variance: the first factor 
explained 34.99% of variance and the second explained 
14.25% of the variance. The first factor was discrimina-
tion (items 17, 18) and the second factor was weak-not-sick 
(items 10, 11, 12). Their correlation was 0.30 (p<0.001). 
It should be noted that for perceived depression stigma, 
the first factor explaining most variance was related to 
discrimination, whereas for personal depression stigma, 
the first factor was related to weak-not-sick.
the two-factor CFA model of the personal and perceived 
stigma subscales
For the personal stigma subscale, the two-factor model 
fitted the data acceptably: S-Bχ2=214.27; df=4; CFI=0.94; 
TLI=0.86; RMSEA=0.093; SRMR=0.04. The χ2 difference 
test indicated that the differences in fit between the 
two-factor model and the initial one-factor model were 
statistically significant (ΔS-Bχ2=2126.00; df=23; p<0.001), 
indicating that the two-factor model fitted better than the 
one-factor model.
For the perceived stigma subscale, the two-factor model 
also fitted the data well: S-Bχ2=24.21; df=4; CFI=0.99; 
TLI=0.99; RMSEA=0.013; SRMR=0.03. The χ2 difference 
test indicated that the two-factor model was better fitting 
than the initial one-factor model (ΔS-Bχ2=2121.78; df=23; 
p<0.001).
the internal consistency and concurrent validity of the 
personal and perceived depression stigma subscale
For the personal depression stigma subscale, the Cron-
bach’s alphas were 0.70 for discrimination, 0.74 for weak-
not-sick and 0.71 for the total score. For the perceived 
depression stigma subscale, the Cronbach’s alphas were 
0.72 for discrimination, 0.80 for weak-not-sick and 0.73 for 
the total score. In terms of concurrent validity, the 5-item 
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Table 4 Correlations between personal and perceived stigma and depressive symptoms (n=301)




2.Personal depression stigma (3-item): weak-not-sick 0.85** –
3.Personal depression stigma (2-item): discrimination 0.69** 0.21** –
4.Perceived depression stigma (5-item) 0.64** 0.47** 0.53** –
5.Perceived depression stigma (2-item): weak-not-sick 0.60** 0.59** 0.30** 0.85** –
6.Perceived depression stigma (3-item): discrimination 0.43** 0.12* 0.59** 0.75** 0.29** –
7.Depressive symptoms 0.15* 0.09 0.13* 0.09 0.10 0.04 –
* p<0.05; ** p<0.01.
positively but weakly related to symptoms of depression 
(p<0.01) (see table 4).
DiSCuSSiOn
The present study is the first to examine the psycho-
metric properties of the DSS in a sample of Chinese 
cancer patients. The results of exploratory and confirma-
tory factor analyses showed that both the personal and 
perceived depression stigma subscales comprised two 
factors rather than one factor, namely, ‘weak-not-sick’ and 
‘discrimination’. The fit of the two-factor models for both 
subscales was found to be adequate to good, as well as 
their reliability in terms of the internal consistency.
Compared with previous studies, we found that Chinese 
people with cancer reported higher levels of personal 
depression stigma but similar levels of perceived depres-
sion stigma than Western people.16 A possible explana-
tion for these discrepancies could be the differences in 
cultural background. In China, people with psychiatric 
or psychological problems often experience higher inter-
nalised stigma than those without psychiatric diseases 
because they are concerned more about moral issue and 
are ashamed of themselves.25 Future cross-cultural studies 
are needed to systematically compare the levels of depres-
sion stigma between Chinese and Western individuals.
A key finding of our study is that personal and perceived 
depression stigma were found not to be unidimensional. 
This is in line with previous research findings in the 
general population and in depressed individuals.16 26 27 
For the personal depression stigma subscale, the current 
study identified two factors: the weak-not-sick (item 1 
‘could snap out of it’, item 2 ‘sign of weakness’ and item 
3 ‘not a real medical illness’) and discrimination (item 
8 ‘would not employ’ and item 9 ‘would not vote for’) 
factors. The identification of the weak-not-sick factor 
(comprising items describing problems of depression as 
a personal weakness under one’s control rather than as 
a medical condition) is in line with previous research, 
although the precise items differ somewhat.16 26 27 A 
finding different from previous research was that the 
discrimination factor (containing items characterising 
discriminative thoughts about people with depression) 
found in both our study and the one by Boerema et al16 
was not identified by the other two studies.26 27 In fact, 
the two items of the discrimination factor in our study 
were part of another factor (ie, dangerous/unpredict-
able) in previous studies.26 27 A possible explanation for 
these different findings may be found in the exclusion of 
items. For both the personal and perceived depression 
stigma subscales, items measuring ‘dangerous’, ‘best to 
avoid’, ‘unpredictable’ and ‘would not tell anyone’ were 
excluded in the current study. However, these excluded 
items were found to comprise the weak-not-sick-avoid-
ance factor and the dangerous/unpredictable factor in 
the personal depression stigma subscale in the previous 
study.16
For the perceived depression stigma, we found a 
two-factor structure (ie, weak-not-sick and discrimination) 
similar to the one we found for the personal depression 
stigma. This differs from Boerema et al,16 who did not find 
a clear structure in the perceived stigma subscale. In our 
study, the items of the two factors of perceived stigma ran 
parallel to the items of the two factors of personal stigma. 
Four items of the perceived depression stigma subscale 
(item 13 dangerous, item 14 best to avoid, item 15 unpre-
dictable and item 16 would not tell anyone) displayed 
low loadings or cross loadings and were removed, which 
is similar to the content of the items excluded in the 
personal depression stigma. Two of these removed themes 
were about depressed people being dangerous or unpre-
dictable, which formed the dangerous/unpredictable 
factor in the general population in Boerema et al.16 Given 
the inconsistent findings regarding the factor structure 
in different types of samples, more research is required 
to test the factor structure of the DSS across different 
cultures and different populations, including cancer 
patients, healthy individuals and depressed persons.
The Chinese version of the DSS demonstrated adequate 
construct validity by explaining 48.86% and 49.25% of 
the variance for the personal and perceived depression 
stigma subscales. Although the explained variances were 
higher than the explained 21% and 19.7% variances of 
the personal stigma scale and perceived stigma scale of 
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almost half of the variance still cannot be explained by the 
DSS. This suggests that there may be other factors influ-
encing cancer patients’ reporting of depression stigma. 
For example, the social distance dimension of depres-
sion stigma, which refers to one’s avoidant behaviour 
rather than beliefs towards people with depression, has 
been found to be separate from personal and perceived 
depression stigma among a community sample and the 
general population.26 27 Including items measuring the 
social distancing of people with depression may help 
improve the construct validity of the instrument’s use for 
measuring depression stigma.
The Cronbach’s alphas of the 5-item personal and 
perceived depression stigma subscales were fair to good, 
which supported internal consistency. However, this 
research found no convincing evidence for the concur-
rent validity of the DSS. The revised personal and 
perceived depression stigma subscales, although statisti-
cally significant, were weakly correlated with depressive 
symptoms. A previous study showed that depressive symp-
toms were related to depression stigma.28
The current study has several limitations. The first is 
that it could not examine the convergent validity of the 
DSS. Future research is required to examine the conver-
gent validity of the DSS in the Chinese cancer population. 
Second, as this study focused on Chinese cancer patients, 
findings cannot be generalised to other populations 
(including healthy or depressed persons) in other coun-
tries. Third, using a cross-sectional design of this study 
made it impossible to examine the test–retest reliability 
of the DSS. A future study using a longitudinal design 
is needed to examine this factor. Fourth, using a self-re-
ported questionnaire for depressive symptoms may have 
caused an overestimation of depressive symptoms. Future 
studies should use a clinical diagnostic instrument (eg, 
CIDI 2.1) to measure depressive symptoms and examine 
the relationships between depression stigma and depres-
sive symptoms.
COnCluSiOnS
The present study suggested that the Chinese version of 
the DSS is a valid and reliable measurement of depression 
stigma in Chinese cancer patients. Using the DSS, clini-
cians and psychologists may pay special attention to how 
Chinese cancer patients perceive depressive symptoms, as 
stigma is likely to be a cause of delays for seeking help.
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